About Anpac Bio
Anpac Bio is a company based in California City (United States) founded in 2010 by Herbert Yu.. Anpac Bio has completed 6 acquisitions, including Fresh2, GISN and GISN. Anpac Bio operates in a competitive market with competitors including Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others.
- Headquarter California City, United States
- Founders Herbert Yu
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Fresh2 Group Limited Spon Ads Each Repr 200 Ord Shs (P/S)
-
Annual Revenue
$1.79 M-35.86as on Dec 31, 2022
-
Net Profit
$-15.13 M17.78as on Dec 31, 2022
-
EBITDA
$-11.68 M27.08as on Dec 31, 2022
-
Latest Funding Round
$5 M (USD), Post-IPO
Mar 01, 2023
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Fresh2
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Anpac Bio
Anpac Bio is a publicly listed company on the OTC with ticker symbol FREHY in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Anpac Bio
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $5.0M
-
First Round
First Round
(30 Sep 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Post-IPO - Anpac Bio | Valuation |
investors |
|
| Sep, 2022 | Amount | Post-IPO - Anpac Bio | Valuation |
investors |
|
| May, 2022 | Amount | Post-IPO - Anpac Bio | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Anpac Bio
Anpac Bio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Keystone Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment firm based in New York is operated.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Anpac Bio
Anpac Bio has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Fresh2, GISN and GISN. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Multi-category grocery products are supplied via an online B2B marketplace.
|
2022 | ||||
|
Technology consulting services are provided by GISN since 2021.
|
2021 | ||||
|
Provider of operation model and technical & outsourcing consulting services
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Anpac Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Anpac Bio Comparisons
Competitors of Anpac Bio
Anpac Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Denali Therapeutics, Foundation Medicine, ArcherDX and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Anpac Bio
Frequently Asked Questions about Anpac Bio
When was Anpac Bio founded?
Anpac Bio was founded in 2010 and raised its 1st funding round 10 years after it was founded.
Where is Anpac Bio located?
Anpac Bio is headquartered in California City, United States. It is registered at California City, California, United States.
What is the annual revenue of Anpac Bio?
Annual revenue of Anpac Bio is $1.79M as on Dec 31, 2022.
What does Anpac Bio do?
Anpac Bio was founded in 2010 in California City, United States, within the biotechnology sector focused on cancer diagnostics. Cancer Differentiation Analysis (CDA) technology is employed to screen for early cancer detection through standard blood samples. Overall cancer risk is evaluated for individuals, and potential tumor locations are identified when combined with existing biomarker tests. Operations center on providing non-invasive screening platforms for risk assessment.
Who are the top competitors of Anpac Bio?
Anpac Bio's top competitors include Guardant Health, Strand Life Sciences and Juno Therapeutics.
Is Anpac Bio publicly traded?
Yes, Anpac Bio is publicly traded on OTC under the ticker symbol FREHY.
How many acquisitions has Anpac Bio made?
Who are Anpac Bio's investors?
Anpac Bio has 1 investor. Key investors include Keystone Capital Partners.
What is Anpac Bio's ticker symbol?
The ticker symbol of Anpac Bio is FREHY on OTC.